| Ms Melissa Rawls Luhmann, MPT | |
|
1145 19th St Nw, Suite 605, Washington, DC 20036-3701 | |
| (202) 833-1003 | |
| (202) 833-2584 |
| Full Name | Ms Melissa Rawls Luhmann |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 1145 19th St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275650996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT870298 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Melissa Rawls Luhmann, MPT 1316 R St Nw Apt 1, Washington, DC 20009-4343 Ph: (202) 265-8968 | Ms Melissa Rawls Luhmann, MPT 1145 19th St Nw, Suite 605, Washington, DC 20036-3701 Ph: (202) 833-1003 |
News Archive
"An attenuated, or weakened, strain of Chlamydia trachomatis bacteria can be used as a vaccine to prevent or reduce the severity of trachoma, the world's leading cause of infectious blindness, suggest findings from a National Institutes of Health (NIH) study in monkeys," an NIH press release reports.
A new study published online June 8 in the Nature publication, Molecular Psychiatry, indicates that postnatal exposure to thimerosal, a mercury preservative commonly used in a number of childhood vaccines, can lead to the development of autism-like damage in autoimmune disease susceptible mice
A neural mapping approach that pegs results from more than two dozen previous Alzheimer's studies found that reproducibility improves when trying to isolate symptoms to a brain network rather than a single area of the brain.
Epeius Biotechnologies Corporation today announces the clinical results of the study entitled "A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol" at the ASCO Annual Meeting on June 6, 2010. The presentation will be made by Dr. Jorge G. Ignacio, Chairman of the Cancer Institute and Bioethics Committee-Philippine General Hospital, and Principal Investigator of the study.
Synta Pharmaceuticals Corp. announced that clinical results for two Phase 1 trials of STA-9090 in solid tumors, as well as 12 month updated survival results from the SYMMETRY trial of elesclomol in metastatic melanoma, were presented at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO).
› Verified 7 days ago
Jeffrey Adam Miller, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1001 G St Nw, Washington, DC 20001 Phone: 202-347-7745 Fax: 202-347-7747 | |
Tyler Allee, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1705 Desales St Nw, 6th Floor, Washington, DC 20036 Phone: 202-630-0378 | |
Bettie R Kruger, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 Pennsylvania Ave Se, Suite 202, Washington, DC 20003 Phone: 202-543-9400 | |
Erin Foley, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1400 Defense St Pentagon, Washington, DC 20310 Phone: 037-692-8982 | |
Triumph Pediatric Center Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4900 Massachusetts Ave Nw # 340, Washington, DC 20016 Phone: 240-336-4976 | |
Vuong Duc Tran, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2021 K St Nw Ste 215, Washington, DC 20006 Phone: 240-898-4446 | |
Mr. Courtland Wyatt, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3700 N Capitol St Nw, Washington, DC 20011 Phone: 800-422-9988 Fax: 301-262-1259 |